Alcyone Lifesciences
VerifiedPioneers next-generation intra-CSF CNS precision gene-based therapeutics for complex neurological conditions.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$92—138m (Dealroom.co estimates Jun 2021.)
Ayer Massachusetts (HQ)
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $0.0 | round | |
N/A | $0.0 | round | |
investor investor | $0.0 | round | |
N/A | $0.0 | round | |
N/A | $0.0 | round | |
$23.0m | Late VC | ||
Total Funding | 000k |
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about Alcyone Lifesciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.